{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.9615376, "regularMarketPrice": 2.1, "exchange": "FRA", "shortName": "ANEBULO PHARMAC.  DL-,001", "longName": "Anebulo Pharmaceuticals, Inc.", "messageBoardId": "finmb_673614867", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "marketState": "REGULAR", "esgPopulated": false, "priceEpsCurrentYear": -3.3870966, "sharesOutstanding": 25633200, "bookValue": 0.605, "fiftyDayAverage": 2.5204, "fiftyDayAverageChange": -0.42040014, "fiftyDayAverageChangePercent": -0.16679898, "twoHundredDayAverage": 2.7523, "twoHundredDayAverageChange": -0.6523001, "twoHundredDayAverageChangePercent": -0.23700182, "marketCap": 57611816, "forwardPE": -4.2, "priceToBook": 3.471074, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1622700000000, "priceHint": 4, "regularMarketChange": 0.01999998, "regularMarketTime": 1683875702, "regularMarketDayHigh": 2.1, "regularMarketDayRange": "2.1 - 2.1", "regularMarketDayLow": 2.1, "regularMarketVolume": 300, "regularMarketPreviousClose": 2.08, "bid": 2.1, "ask": 2.18, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.1, "averageDailyVolume3Month": 5, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.099999905, "fiftyTwoWeekLowChangePercent": 0.049999952, "fiftyTwoWeekRange": "2.0 - 4.32", "fiftyTwoWeekHighChange": -2.2200003, "fiftyTwoWeekHighChangePercent": -0.51388896, "fiftyTwoWeekLow": 2.0, "fiftyTwoWeekHigh": 4.32, "earningsTimestamp": 1683806400, "earningsTimestampStart": 1683806400, "earningsTimestampEnd": 1683806400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.38, "epsForward": -0.5, "epsCurrentYear": -0.62, "symbol": "214.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1415 Ranch Road 620 South", "address2": "Suite 201", "city": "Lakeway", "state": "TX", "zip": "78734", "country": "United States", "phone": "512-598-0931", "website": "https://www.anebulo.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joseph F. Lawler M.D., Ph.D.", "age": 50, "title": "Founder & Chairman", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 11000, "fmt": "11k", "longFmt": "11,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon J. Allen B.Sc., M.B.A., MBA", "age": 54, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 450000, "fmt": "450k", "longFmt": "450,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kenneth C. Cundy Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 345526, "fmt": "345.53k", "longFmt": "345,526"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 33411, "fmt": "33.41k", "longFmt": "33,411"}}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 56, "title": "Acting Chief Financial Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott L. Anderson", "title": "Head of Investor Relations & Public Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}